Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: press release (2)
press release
investor
nutraceuticals
video
science
eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months
July 22, 2025
press release
investor
nutraceuticals
medicine
science
eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing
June 26, 2025
heltzen
press release
investor
press clippings
Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'
May 16, 2025
press release
investor
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
May 12, 2025
press release
investor
eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
May 7, 2025
press release
investor
nutraceuticals
medicine
science
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
May 6, 2025
press release
investor
video
science
GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes
April 21, 2025
press release
investor
science
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
April 10, 2025
talent
press release
investor
video
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
April 2, 2025
press release
investor
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
April 2, 2025
Previous page
Page 2 of 4
Next page